Global Cell Gene Therapy Biomanufacturing Market Research Report 2026(Status and Outlook)
Cell and gene therapy (CGT) includes the injection of cells, genes, or gene-modified cells into a patient with the purpose of preventing or treating a disease. Cell therapy involves the injection of cells to replace or aid the repair of damaged cells, whereas gene therapy involves the injection of genes into cells to alter the genetic makeup of the recipient cells. Cell-based gene therapies, such as chimeric antigen receptor T (CAR-T) therapy, represent combinations of both approaches.In recent years, the demand for cell and gene therapy (CGT) has surged as the number of United States Food and Drug Administration (U.S. FDA)-approved CGT products has increased annually. This increasing demand underscores the pressing need for manufacturers to improve and advance their production processes to keep pace with the rapidly evolving CGT field. The entire CGT manufacturing process must occur in a facility that complies with good manufacturing practice (GMP) regulations and has received full authorization to manufacture CGTs or advanced-therapy medicinal products, as they are referred to in Europe, for human use. Numerous clinical trials have been conducted to assess the safety and efficacy of CGTs for a wide range of clinical indications, including cancer.
The global Cell Gene Therapy Biomanufacturing market size was estimated at USD 15410.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cell Gene Therapy Biomanufacturing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cell Gene Therapy Biomanufacturing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cell Gene Therapy Biomanufacturing market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell Gene Therapy Biomanufacturing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cell Gene Therapy Biomanufacturing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global Cell Gene Therapy Biomanufacturing market size was estimated at USD 15410.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cell Gene Therapy Biomanufacturing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cell Gene Therapy Biomanufacturing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cell Gene Therapy Biomanufacturing market.
Global Cell Gene Therapy Biomanufacturing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Lonza Group
- Thermo Fisher Scientific Inc.
- Merck KGaA
- WuXi AppTec
- Catalent, Inc.
- Samsung Biologics
- FUJIFILM Diosynth Biotechnologies
- Charles River Laboratories
- Cytiva
- Novasep
Market Segmentation (by Type)
- Consumables
- Equipment
- Software Solutions
Market Segmentation (by Application)
- Life Science Companies
- Contract Research Organizations
- Contract Manufacturing Organizations
- Cell Banks
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Cell Gene Therapy Biomanufacturing Market
Overview of the regional outlook of the Cell Gene Therapy Biomanufacturing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell Gene Therapy Biomanufacturing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cell Gene Therapy Biomanufacturing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cell Gene Therapy Biomanufacturing
1.2 Key Market Segments
1.2.1 Cell Gene Therapy Biomanufacturing Segment by Type
1.2.2 Cell Gene Therapy Biomanufacturing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELL GENE THERAPY BIOMANUFACTURING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cell Gene Therapy Biomanufacturing Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Cell Gene Therapy Biomanufacturing Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELL GENE THERAPY BIOMANUFACTURING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cell Gene Therapy Biomanufacturing Product Life Cycle
3.3 Global Cell Gene Therapy Biomanufacturing Sales by Manufacturers (2020-2025)
3.4 Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Manufacturers (2020-2025)
3.5 Cell Gene Therapy Biomanufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cell Gene Therapy Biomanufacturing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Cell Gene Therapy Biomanufacturing Market Competitive Situation and Trends
3.8.1 Cell Gene Therapy Biomanufacturing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cell Gene Therapy Biomanufacturing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CELL GENE THERAPY BIOMANUFACTURING INDUSTRY CHAIN ANALYSIS
4.1 Cell Gene Therapy Biomanufacturing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELL GENE THERAPY BIOMANUFACTURING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cell Gene Therapy Biomanufacturing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cell Gene Therapy Biomanufacturing Market
5.7 ESG Ratings of Leading Companies
6 CELL GENE THERAPY BIOMANUFACTURING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell Gene Therapy Biomanufacturing Sales Market Share by Type (2020-2025)
6.3 Global Cell Gene Therapy Biomanufacturing Market Size by Type (2020-2025)
6.4 Global Cell Gene Therapy Biomanufacturing Price by Type (2020-2025)
7 CELL GENE THERAPY BIOMANUFACTURING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell Gene Therapy Biomanufacturing Market Sales by Application (2020-2025)
7.3 Global Cell Gene Therapy Biomanufacturing Market Size (M USD) by Application (2020-2025)
7.4 Global Cell Gene Therapy Biomanufacturing Sales Growth Rate by Application (2020-2025)
8 CELL GENE THERAPY BIOMANUFACTURING MARKET SALES BY REGION
8.1 Global Cell Gene Therapy Biomanufacturing Sales by Region
8.1.1 Global Cell Gene Therapy Biomanufacturing Sales by Region
8.1.2 Global Cell Gene Therapy Biomanufacturing Sales Market Share by Region
8.2 Global Cell Gene Therapy Biomanufacturing Market Size by Region
8.2.1 Global Cell Gene Therapy Biomanufacturing Market Size by Region
8.2.2 Global Cell Gene Therapy Biomanufacturing Market Size by Region
8.3 North America
8.3.1 North America Cell Gene Therapy Biomanufacturing Sales by Country
8.3.2 North America Cell Gene Therapy Biomanufacturing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cell Gene Therapy Biomanufacturing Sales by Country
8.4.2 Europe Cell Gene Therapy Biomanufacturing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cell Gene Therapy Biomanufacturing Sales by Region
8.5.2 Asia Pacific Cell Gene Therapy Biomanufacturing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cell Gene Therapy Biomanufacturing Sales by Country
8.6.2 South America Cell Gene Therapy Biomanufacturing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cell Gene Therapy Biomanufacturing Sales by Region
8.7.2 Middle East and Africa Cell Gene Therapy Biomanufacturing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CELL GENE THERAPY BIOMANUFACTURING MARKET PRODUCTION BY REGION
9.1 Global Production of Cell Gene Therapy Biomanufacturing by Region(2020-2025)
9.2 Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Region (2020-2025)
9.3 Global Cell Gene Therapy Biomanufacturing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cell Gene Therapy Biomanufacturing Production
9.4.1 North America Cell Gene Therapy Biomanufacturing Production Growth Rate (2020-2025)
9.4.2 North America Cell Gene Therapy Biomanufacturing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cell Gene Therapy Biomanufacturing Production
9.5.1 Europe Cell Gene Therapy Biomanufacturing Production Growth Rate (2020-2025)
9.5.2 Europe Cell Gene Therapy Biomanufacturing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cell Gene Therapy Biomanufacturing Production (2020-2025)
9.6.1 Japan Cell Gene Therapy Biomanufacturing Production Growth Rate (2020-2025)
9.6.2 Japan Cell Gene Therapy Biomanufacturing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cell Gene Therapy Biomanufacturing Production (2020-2025)
9.7.1 China Cell Gene Therapy Biomanufacturing Production Growth Rate (2020-2025)
9.7.2 China Cell Gene Therapy Biomanufacturing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Lonza Group
10.1.1 Lonza Group Basic Information
10.1.2 Lonza Group Cell Gene Therapy Biomanufacturing Product Overview
10.1.3 Lonza Group Cell Gene Therapy Biomanufacturing Product Market Performance
10.1.4 Lonza Group Business Overview
10.1.5 Lonza Group SWOT Analysis
10.1.6 Lonza Group Recent Developments
10.2 Thermo Fisher Scientific Inc.
10.2.1 Thermo Fisher Scientific Inc. Basic Information
10.2.2 Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Product Overview
10.2.3 Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Product Market Performance
10.2.4 Thermo Fisher Scientific Inc. Business Overview
10.2.5 Thermo Fisher Scientific Inc. SWOT Analysis
10.2.6 Thermo Fisher Scientific Inc. Recent Developments
10.3 Merck KGaA
10.3.1 Merck KGaA Basic Information
10.3.2 Merck KGaA Cell Gene Therapy Biomanufacturing Product Overview
10.3.3 Merck KGaA Cell Gene Therapy Biomanufacturing Product Market Performance
10.3.4 Merck KGaA Business Overview
10.3.5 Merck KGaA SWOT Analysis
10.3.6 Merck KGaA Recent Developments
10.4 WuXi AppTec
10.4.1 WuXi AppTec Basic Information
10.4.2 WuXi AppTec Cell Gene Therapy Biomanufacturing Product Overview
10.4.3 WuXi AppTec Cell Gene Therapy Biomanufacturing Product Market Performance
10.4.4 WuXi AppTec Business Overview
10.4.5 WuXi AppTec Recent Developments
10.5 Catalent, Inc.
10.5.1 Catalent, Inc. Basic Information
10.5.2 Catalent, Inc. Cell Gene Therapy Biomanufacturing Product Overview
10.5.3 Catalent, Inc. Cell Gene Therapy Biomanufacturing Product Market Performance
10.5.4 Catalent, Inc. Business Overview
10.5.5 Catalent, Inc. Recent Developments
10.6 Samsung Biologics
10.6.1 Samsung Biologics Basic Information
10.6.2 Samsung Biologics Cell Gene Therapy Biomanufacturing Product Overview
10.6.3 Samsung Biologics Cell Gene Therapy Biomanufacturing Product Market Performance
10.6.4 Samsung Biologics Business Overview
10.6.5 Samsung Biologics Recent Developments
10.7 FUJIFILM Diosynth Biotechnologies
10.7.1 FUJIFILM Diosynth Biotechnologies Basic Information
10.7.2 FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Product Overview
10.7.3 FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Product Market Performance
10.7.4 FUJIFILM Diosynth Biotechnologies Business Overview
10.7.5 FUJIFILM Diosynth Biotechnologies Recent Developments
10.8 Charles River Laboratories
10.8.1 Charles River Laboratories Basic Information
10.8.2 Charles River Laboratories Cell Gene Therapy Biomanufacturing Product Overview
10.8.3 Charles River Laboratories Cell Gene Therapy Biomanufacturing Product Market Performance
10.8.4 Charles River Laboratories Business Overview
10.8.5 Charles River Laboratories Recent Developments
10.9 Cytiva
10.9.1 Cytiva Basic Information
10.9.2 Cytiva Cell Gene Therapy Biomanufacturing Product Overview
10.9.3 Cytiva Cell Gene Therapy Biomanufacturing Product Market Performance
10.9.4 Cytiva Business Overview
10.9.5 Cytiva Recent Developments
10.10 Novasep
10.10.1 Novasep Basic Information
10.10.2 Novasep Cell Gene Therapy Biomanufacturing Product Overview
10.10.3 Novasep Cell Gene Therapy Biomanufacturing Product Market Performance
10.10.4 Novasep Business Overview
10.10.5 Novasep Recent Developments
11 CELL GENE THERAPY BIOMANUFACTURING MARKET FORECAST BY REGION
11.1 Global Cell Gene Therapy Biomanufacturing Market Size Forecast
11.2 Global Cell Gene Therapy Biomanufacturing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cell Gene Therapy Biomanufacturing Market Size Forecast by Country
11.2.3 Asia Pacific Cell Gene Therapy Biomanufacturing Market Size Forecast by Region
11.2.4 South America Cell Gene Therapy Biomanufacturing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cell Gene Therapy Biomanufacturing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Cell Gene Therapy Biomanufacturing Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Cell Gene Therapy Biomanufacturing by Type (2026-2035)
12.1.2 Global Cell Gene Therapy Biomanufacturing Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Cell Gene Therapy Biomanufacturing by Type (2026-2035)
12.2 Global Cell Gene Therapy Biomanufacturing Market Forecast by Application (2026-2035)
12.2.1 Global Cell Gene Therapy Biomanufacturing Sales (K Units) Forecast by Application
12.2.2 Global Cell Gene Therapy Biomanufacturing Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Cell Gene Therapy Biomanufacturing
1.2 Key Market Segments
1.2.1 Cell Gene Therapy Biomanufacturing Segment by Type
1.2.2 Cell Gene Therapy Biomanufacturing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELL GENE THERAPY BIOMANUFACTURING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cell Gene Therapy Biomanufacturing Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Cell Gene Therapy Biomanufacturing Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELL GENE THERAPY BIOMANUFACTURING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cell Gene Therapy Biomanufacturing Product Life Cycle
3.3 Global Cell Gene Therapy Biomanufacturing Sales by Manufacturers (2020-2025)
3.4 Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Manufacturers (2020-2025)
3.5 Cell Gene Therapy Biomanufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cell Gene Therapy Biomanufacturing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Cell Gene Therapy Biomanufacturing Market Competitive Situation and Trends
3.8.1 Cell Gene Therapy Biomanufacturing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cell Gene Therapy Biomanufacturing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CELL GENE THERAPY BIOMANUFACTURING INDUSTRY CHAIN ANALYSIS
4.1 Cell Gene Therapy Biomanufacturing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELL GENE THERAPY BIOMANUFACTURING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cell Gene Therapy Biomanufacturing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cell Gene Therapy Biomanufacturing Market
5.7 ESG Ratings of Leading Companies
6 CELL GENE THERAPY BIOMANUFACTURING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell Gene Therapy Biomanufacturing Sales Market Share by Type (2020-2025)
6.3 Global Cell Gene Therapy Biomanufacturing Market Size by Type (2020-2025)
6.4 Global Cell Gene Therapy Biomanufacturing Price by Type (2020-2025)
7 CELL GENE THERAPY BIOMANUFACTURING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell Gene Therapy Biomanufacturing Market Sales by Application (2020-2025)
7.3 Global Cell Gene Therapy Biomanufacturing Market Size (M USD) by Application (2020-2025)
7.4 Global Cell Gene Therapy Biomanufacturing Sales Growth Rate by Application (2020-2025)
8 CELL GENE THERAPY BIOMANUFACTURING MARKET SALES BY REGION
8.1 Global Cell Gene Therapy Biomanufacturing Sales by Region
8.1.1 Global Cell Gene Therapy Biomanufacturing Sales by Region
8.1.2 Global Cell Gene Therapy Biomanufacturing Sales Market Share by Region
8.2 Global Cell Gene Therapy Biomanufacturing Market Size by Region
8.2.1 Global Cell Gene Therapy Biomanufacturing Market Size by Region
8.2.2 Global Cell Gene Therapy Biomanufacturing Market Size by Region
8.3 North America
8.3.1 North America Cell Gene Therapy Biomanufacturing Sales by Country
8.3.2 North America Cell Gene Therapy Biomanufacturing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cell Gene Therapy Biomanufacturing Sales by Country
8.4.2 Europe Cell Gene Therapy Biomanufacturing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cell Gene Therapy Biomanufacturing Sales by Region
8.5.2 Asia Pacific Cell Gene Therapy Biomanufacturing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cell Gene Therapy Biomanufacturing Sales by Country
8.6.2 South America Cell Gene Therapy Biomanufacturing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cell Gene Therapy Biomanufacturing Sales by Region
8.7.2 Middle East and Africa Cell Gene Therapy Biomanufacturing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CELL GENE THERAPY BIOMANUFACTURING MARKET PRODUCTION BY REGION
9.1 Global Production of Cell Gene Therapy Biomanufacturing by Region(2020-2025)
9.2 Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Region (2020-2025)
9.3 Global Cell Gene Therapy Biomanufacturing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cell Gene Therapy Biomanufacturing Production
9.4.1 North America Cell Gene Therapy Biomanufacturing Production Growth Rate (2020-2025)
9.4.2 North America Cell Gene Therapy Biomanufacturing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cell Gene Therapy Biomanufacturing Production
9.5.1 Europe Cell Gene Therapy Biomanufacturing Production Growth Rate (2020-2025)
9.5.2 Europe Cell Gene Therapy Biomanufacturing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cell Gene Therapy Biomanufacturing Production (2020-2025)
9.6.1 Japan Cell Gene Therapy Biomanufacturing Production Growth Rate (2020-2025)
9.6.2 Japan Cell Gene Therapy Biomanufacturing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cell Gene Therapy Biomanufacturing Production (2020-2025)
9.7.1 China Cell Gene Therapy Biomanufacturing Production Growth Rate (2020-2025)
9.7.2 China Cell Gene Therapy Biomanufacturing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Lonza Group
10.1.1 Lonza Group Basic Information
10.1.2 Lonza Group Cell Gene Therapy Biomanufacturing Product Overview
10.1.3 Lonza Group Cell Gene Therapy Biomanufacturing Product Market Performance
10.1.4 Lonza Group Business Overview
10.1.5 Lonza Group SWOT Analysis
10.1.6 Lonza Group Recent Developments
10.2 Thermo Fisher Scientific Inc.
10.2.1 Thermo Fisher Scientific Inc. Basic Information
10.2.2 Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Product Overview
10.2.3 Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Product Market Performance
10.2.4 Thermo Fisher Scientific Inc. Business Overview
10.2.5 Thermo Fisher Scientific Inc. SWOT Analysis
10.2.6 Thermo Fisher Scientific Inc. Recent Developments
10.3 Merck KGaA
10.3.1 Merck KGaA Basic Information
10.3.2 Merck KGaA Cell Gene Therapy Biomanufacturing Product Overview
10.3.3 Merck KGaA Cell Gene Therapy Biomanufacturing Product Market Performance
10.3.4 Merck KGaA Business Overview
10.3.5 Merck KGaA SWOT Analysis
10.3.6 Merck KGaA Recent Developments
10.4 WuXi AppTec
10.4.1 WuXi AppTec Basic Information
10.4.2 WuXi AppTec Cell Gene Therapy Biomanufacturing Product Overview
10.4.3 WuXi AppTec Cell Gene Therapy Biomanufacturing Product Market Performance
10.4.4 WuXi AppTec Business Overview
10.4.5 WuXi AppTec Recent Developments
10.5 Catalent, Inc.
10.5.1 Catalent, Inc. Basic Information
10.5.2 Catalent, Inc. Cell Gene Therapy Biomanufacturing Product Overview
10.5.3 Catalent, Inc. Cell Gene Therapy Biomanufacturing Product Market Performance
10.5.4 Catalent, Inc. Business Overview
10.5.5 Catalent, Inc. Recent Developments
10.6 Samsung Biologics
10.6.1 Samsung Biologics Basic Information
10.6.2 Samsung Biologics Cell Gene Therapy Biomanufacturing Product Overview
10.6.3 Samsung Biologics Cell Gene Therapy Biomanufacturing Product Market Performance
10.6.4 Samsung Biologics Business Overview
10.6.5 Samsung Biologics Recent Developments
10.7 FUJIFILM Diosynth Biotechnologies
10.7.1 FUJIFILM Diosynth Biotechnologies Basic Information
10.7.2 FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Product Overview
10.7.3 FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Product Market Performance
10.7.4 FUJIFILM Diosynth Biotechnologies Business Overview
10.7.5 FUJIFILM Diosynth Biotechnologies Recent Developments
10.8 Charles River Laboratories
10.8.1 Charles River Laboratories Basic Information
10.8.2 Charles River Laboratories Cell Gene Therapy Biomanufacturing Product Overview
10.8.3 Charles River Laboratories Cell Gene Therapy Biomanufacturing Product Market Performance
10.8.4 Charles River Laboratories Business Overview
10.8.5 Charles River Laboratories Recent Developments
10.9 Cytiva
10.9.1 Cytiva Basic Information
10.9.2 Cytiva Cell Gene Therapy Biomanufacturing Product Overview
10.9.3 Cytiva Cell Gene Therapy Biomanufacturing Product Market Performance
10.9.4 Cytiva Business Overview
10.9.5 Cytiva Recent Developments
10.10 Novasep
10.10.1 Novasep Basic Information
10.10.2 Novasep Cell Gene Therapy Biomanufacturing Product Overview
10.10.3 Novasep Cell Gene Therapy Biomanufacturing Product Market Performance
10.10.4 Novasep Business Overview
10.10.5 Novasep Recent Developments
11 CELL GENE THERAPY BIOMANUFACTURING MARKET FORECAST BY REGION
11.1 Global Cell Gene Therapy Biomanufacturing Market Size Forecast
11.2 Global Cell Gene Therapy Biomanufacturing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cell Gene Therapy Biomanufacturing Market Size Forecast by Country
11.2.3 Asia Pacific Cell Gene Therapy Biomanufacturing Market Size Forecast by Region
11.2.4 South America Cell Gene Therapy Biomanufacturing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cell Gene Therapy Biomanufacturing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Cell Gene Therapy Biomanufacturing Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Cell Gene Therapy Biomanufacturing by Type (2026-2035)
12.1.2 Global Cell Gene Therapy Biomanufacturing Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Cell Gene Therapy Biomanufacturing by Type (2026-2035)
12.2 Global Cell Gene Therapy Biomanufacturing Market Forecast by Application (2026-2035)
12.2.1 Global Cell Gene Therapy Biomanufacturing Sales (K Units) Forecast by Application
12.2.2 Global Cell Gene Therapy Biomanufacturing Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cell Gene Therapy Biomanufacturing Market Size by Type (M USD)
Table 4. Global Cell Gene Therapy Biomanufacturing Market Size by Application
Table 5. Cell Gene Therapy Biomanufacturing Market Size Comparison by Region (M USD)
Table 6. Global Cell Gene Therapy Biomanufacturing Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Cell Gene Therapy Biomanufacturing Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Cell Gene Therapy Biomanufacturing Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Cell Gene Therapy Biomanufacturing Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Gene Therapy Biomanufacturing as of 2025)
Table 11. Global Market Cell Gene Therapy Biomanufacturing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Cell Gene Therapy Biomanufacturing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cell Gene Therapy Biomanufacturing Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Cell Gene Therapy Biomanufacturing Sales by Type (K Units)
Table 27. Global Cell Gene Therapy Biomanufacturing Market Size by Type (M USD)
Table 28. Global Cell Gene Therapy Biomanufacturing Sales (K Units) by Type (2020-2025)
Table 29. Global Cell Gene Therapy Biomanufacturing Sales Market Share by Type (2020-2025)
Table 30. Global Cell Gene Therapy Biomanufacturing Market Size (M USD) by Type (2020-2025)
Table 31. Global Cell Gene Therapy Biomanufacturing Market Share by Type (2020-2025)
Table 32. Global Cell Gene Therapy Biomanufacturing Price (USD/Unit) by Type (2020-2025)
Table 33. Global Cell Gene Therapy Biomanufacturing Sales (K Units) by Application
Table 34. Global Cell Gene Therapy Biomanufacturing Market Size by Application
Table 35. Global Cell Gene Therapy Biomanufacturing Sales by Application (2020-2025) & (K Units)
Table 36. Global Cell Gene Therapy Biomanufacturing Sales Market Share by Application (2020-2025)
Table 37. Global Cell Gene Therapy Biomanufacturing Market Size by Application (2020-2025) & (M USD)
Table 38. Global Cell Gene Therapy Biomanufacturing Market Share by Application (2020-2025)
Table 39. Global Cell Gene Therapy Biomanufacturing Sales Growth Rate by Application (2020-2025)
Table 40. Global Cell Gene Therapy Biomanufacturing Sales by Region (2020-2025) & (K Units)
Table 41. Global Cell Gene Therapy Biomanufacturing Sales Market Share by Region (2020-2025)
Table 42. Global Cell Gene Therapy Biomanufacturing Market Size by Region (2020-2025) & (M USD)
Table 43. Global Cell Gene Therapy Biomanufacturing Market Size by Region (2020-2025)
Table 44. North America Cell Gene Therapy Biomanufacturing Sales by Country (2020-2025) & (K Units)
Table 45. North America Cell Gene Therapy Biomanufacturing Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Cell Gene Therapy Biomanufacturing Sales by Country (2020-2025) & (K Units)
Table 47. Europe Cell Gene Therapy Biomanufacturing Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Cell Gene Therapy Biomanufacturing Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Cell Gene Therapy Biomanufacturing Market Size by Region (2020-2025) & (M USD)
Table 50. South America Cell Gene Therapy Biomanufacturing Sales by Country (2020-2025) & (K Units)
Table 51. South America Cell Gene Therapy Biomanufacturing Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Cell Gene Therapy Biomanufacturing Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Cell Gene Therapy Biomanufacturing Market Size by Region (2020-2025) & (M USD)
Table 54. Global Cell Gene Therapy Biomanufacturing Production (K Units) by Region(2020-2025)
Table 55. Global Cell Gene Therapy Biomanufacturing Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Region (2020-2025)
Table 57. Global Cell Gene Therapy Biomanufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Cell Gene Therapy Biomanufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Cell Gene Therapy Biomanufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Cell Gene Therapy Biomanufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Cell Gene Therapy Biomanufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Lonza Group Basic Information
Table 63. Lonza Group Cell Gene Therapy Biomanufacturing Product Overview
Table 64. Lonza Group Cell Gene Therapy Biomanufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Lonza Group Business Overview
Table 66. Lonza Group SWOT Analysis
Table 67. Lonza Group Recent Developments
Table 68. Thermo Fisher Scientific Inc. Basic Information
Table 69. Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Product Overview
Table 70. Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Thermo Fisher Scientific Inc. Business Overview
Table 72. Thermo Fisher Scientific Inc. SWOT Analysis
Table 73. Thermo Fisher Scientific Inc. Recent Developments
Table 74. Merck KGaA Basic Information
Table 75. Merck KGaA Cell Gene Therapy Biomanufacturing Product Overview
Table 76. Merck KGaA Cell Gene Therapy Biomanufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Merck KGaA Business Overview
Table 78. Merck KGaA SWOT Analysis
Table 79. Merck KGaA Recent Developments
Table 80. WuXi AppTec Basic Information
Table 81. WuXi AppTec Cell Gene Therapy Biomanufacturing Product Overview
Table 82. WuXi AppTec Cell Gene Therapy Biomanufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. WuXi AppTec Business Overview
Table 84. WuXi AppTec Recent Developments
Table 85. Catalent, Inc. Basic Information
Table 86. Catalent, Inc. Cell Gene Therapy Biomanufacturing Product Overview
Table 87. Catalent, Inc. Cell Gene Therapy Biomanufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Catalent, Inc. Business Overview
Table 89. Catalent, Inc. Recent Developments
Table 90. Samsung Biologics Basic Information
Table 91. Samsung Biologics Cell Gene Therapy Biomanufacturing Product Overview
Table 92. Samsung Biologics Cell Gene Therapy Biomanufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Samsung Biologics Business Overview
Table 94. Samsung Biologics Recent Developments
Table 95. FUJIFILM Diosynth Biotechnologies Basic Information
Table 96. FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Product Overview
Table 97. FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. FUJIFILM Diosynth Biotechnologies Business Overview
Table 99. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 100. Charles River Laboratories Basic Information
Table 101. Charles River Laboratories Cell Gene Therapy Biomanufacturing Product Overview
Table 102. Charles River Laboratories Cell Gene Therapy Biomanufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Charles River Laboratories Business Overview
Table 104. Charles River Laboratories Recent Developments
Table 105. Cytiva Basic Information
Table 106. Cytiva Cell Gene Therapy Biomanufacturing Product Overview
Table 107. Cytiva Cell Gene Therapy Biomanufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Cytiva Business Overview
Table 109. Cytiva Recent Developments
Table 110. Novasep Basic Information
Table 111. Novasep Cell Gene Therapy Biomanufacturing Product Overview
Table 112. Novasep Cell Gene Therapy Biomanufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Novasep Business Overview
Table 114. Novasep Recent Developments
Table 115. Global Cell Gene Therapy Biomanufacturing Sales Forecast by Region (2026-2035) & (K Units)
Table 116. Global Cell Gene Therapy Biomanufacturing Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Cell Gene Therapy Biomanufacturing Sales Forecast by Country (2026-2035) & (K Units)
Table 118. North America Cell Gene Therapy Biomanufacturing Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Cell Gene Therapy Biomanufacturing Sales Forecast by Country (2026-2035) & (K Units)
Table 120. Europe Cell Gene Therapy Biomanufacturing Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Cell Gene Therapy Biomanufacturing Sales Forecast by Region (2026-2035) & (K Units)
Table 122. Asia Pacific Cell Gene Therapy Biomanufacturing Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Cell Gene Therapy Biomanufacturing Sales Forecast by Country (2026-2035) & (K Units)
Table 124. South America Cell Gene Therapy Biomanufacturing Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Cell Gene Therapy Biomanufacturing Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Cell Gene Therapy Biomanufacturing Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Cell Gene Therapy Biomanufacturing Sales Forecast by Type (2026-2035) & (K Units)
Table 128. Global Cell Gene Therapy Biomanufacturing Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Cell Gene Therapy Biomanufacturing Price Forecast by Type (2026-2035) & (USD/Unit)
Table 130. Global Cell Gene Therapy Biomanufacturing Sales (K Units) Forecast by Application (2026-2035)
Table 131. Global Cell Gene Therapy Biomanufacturing Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cell Gene Therapy Biomanufacturing Market Size by Type (M USD)
Table 4. Global Cell Gene Therapy Biomanufacturing Market Size by Application
Table 5. Cell Gene Therapy Biomanufacturing Market Size Comparison by Region (M USD)
Table 6. Global Cell Gene Therapy Biomanufacturing Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Cell Gene Therapy Biomanufacturing Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Cell Gene Therapy Biomanufacturing Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Cell Gene Therapy Biomanufacturing Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Gene Therapy Biomanufacturing as of 2025)
Table 11. Global Market Cell Gene Therapy Biomanufacturing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Cell Gene Therapy Biomanufacturing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cell Gene Therapy Biomanufacturing Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Cell Gene Therapy Biomanufacturing Sales by Type (K Units)
Table 27. Global Cell Gene Therapy Biomanufacturing Market Size by Type (M USD)
Table 28. Global Cell Gene Therapy Biomanufacturing Sales (K Units) by Type (2020-2025)
Table 29. Global Cell Gene Therapy Biomanufacturing Sales Market Share by Type (2020-2025)
Table 30. Global Cell Gene Therapy Biomanufacturing Market Size (M USD) by Type (2020-2025)
Table 31. Global Cell Gene Therapy Biomanufacturing Market Share by Type (2020-2025)
Table 32. Global Cell Gene Therapy Biomanufacturing Price (USD/Unit) by Type (2020-2025)
Table 33. Global Cell Gene Therapy Biomanufacturing Sales (K Units) by Application
Table 34. Global Cell Gene Therapy Biomanufacturing Market Size by Application
Table 35. Global Cell Gene Therapy Biomanufacturing Sales by Application (2020-2025) & (K Units)
Table 36. Global Cell Gene Therapy Biomanufacturing Sales Market Share by Application (2020-2025)
Table 37. Global Cell Gene Therapy Biomanufacturing Market Size by Application (2020-2025) & (M USD)
Table 38. Global Cell Gene Therapy Biomanufacturing Market Share by Application (2020-2025)
Table 39. Global Cell Gene Therapy Biomanufacturing Sales Growth Rate by Application (2020-2025)
Table 40. Global Cell Gene Therapy Biomanufacturing Sales by Region (2020-2025) & (K Units)
Table 41. Global Cell Gene Therapy Biomanufacturing Sales Market Share by Region (2020-2025)
Table 42. Global Cell Gene Therapy Biomanufacturing Market Size by Region (2020-2025) & (M USD)
Table 43. Global Cell Gene Therapy Biomanufacturing Market Size by Region (2020-2025)
Table 44. North America Cell Gene Therapy Biomanufacturing Sales by Country (2020-2025) & (K Units)
Table 45. North America Cell Gene Therapy Biomanufacturing Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Cell Gene Therapy Biomanufacturing Sales by Country (2020-2025) & (K Units)
Table 47. Europe Cell Gene Therapy Biomanufacturing Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Cell Gene Therapy Biomanufacturing Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Cell Gene Therapy Biomanufacturing Market Size by Region (2020-2025) & (M USD)
Table 50. South America Cell Gene Therapy Biomanufacturing Sales by Country (2020-2025) & (K Units)
Table 51. South America Cell Gene Therapy Biomanufacturing Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Cell Gene Therapy Biomanufacturing Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Cell Gene Therapy Biomanufacturing Market Size by Region (2020-2025) & (M USD)
Table 54. Global Cell Gene Therapy Biomanufacturing Production (K Units) by Region(2020-2025)
Table 55. Global Cell Gene Therapy Biomanufacturing Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Region (2020-2025)
Table 57. Global Cell Gene Therapy Biomanufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Cell Gene Therapy Biomanufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Cell Gene Therapy Biomanufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Cell Gene Therapy Biomanufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Cell Gene Therapy Biomanufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Lonza Group Basic Information
Table 63. Lonza Group Cell Gene Therapy Biomanufacturing Product Overview
Table 64. Lonza Group Cell Gene Therapy Biomanufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Lonza Group Business Overview
Table 66. Lonza Group SWOT Analysis
Table 67. Lonza Group Recent Developments
Table 68. Thermo Fisher Scientific Inc. Basic Information
Table 69. Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Product Overview
Table 70. Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Thermo Fisher Scientific Inc. Business Overview
Table 72. Thermo Fisher Scientific Inc. SWOT Analysis
Table 73. Thermo Fisher Scientific Inc. Recent Developments
Table 74. Merck KGaA Basic Information
Table 75. Merck KGaA Cell Gene Therapy Biomanufacturing Product Overview
Table 76. Merck KGaA Cell Gene Therapy Biomanufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Merck KGaA Business Overview
Table 78. Merck KGaA SWOT Analysis
Table 79. Merck KGaA Recent Developments
Table 80. WuXi AppTec Basic Information
Table 81. WuXi AppTec Cell Gene Therapy Biomanufacturing Product Overview
Table 82. WuXi AppTec Cell Gene Therapy Biomanufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. WuXi AppTec Business Overview
Table 84. WuXi AppTec Recent Developments
Table 85. Catalent, Inc. Basic Information
Table 86. Catalent, Inc. Cell Gene Therapy Biomanufacturing Product Overview
Table 87. Catalent, Inc. Cell Gene Therapy Biomanufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Catalent, Inc. Business Overview
Table 89. Catalent, Inc. Recent Developments
Table 90. Samsung Biologics Basic Information
Table 91. Samsung Biologics Cell Gene Therapy Biomanufacturing Product Overview
Table 92. Samsung Biologics Cell Gene Therapy Biomanufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Samsung Biologics Business Overview
Table 94. Samsung Biologics Recent Developments
Table 95. FUJIFILM Diosynth Biotechnologies Basic Information
Table 96. FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Product Overview
Table 97. FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. FUJIFILM Diosynth Biotechnologies Business Overview
Table 99. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 100. Charles River Laboratories Basic Information
Table 101. Charles River Laboratories Cell Gene Therapy Biomanufacturing Product Overview
Table 102. Charles River Laboratories Cell Gene Therapy Biomanufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Charles River Laboratories Business Overview
Table 104. Charles River Laboratories Recent Developments
Table 105. Cytiva Basic Information
Table 106. Cytiva Cell Gene Therapy Biomanufacturing Product Overview
Table 107. Cytiva Cell Gene Therapy Biomanufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Cytiva Business Overview
Table 109. Cytiva Recent Developments
Table 110. Novasep Basic Information
Table 111. Novasep Cell Gene Therapy Biomanufacturing Product Overview
Table 112. Novasep Cell Gene Therapy Biomanufacturing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Novasep Business Overview
Table 114. Novasep Recent Developments
Table 115. Global Cell Gene Therapy Biomanufacturing Sales Forecast by Region (2026-2035) & (K Units)
Table 116. Global Cell Gene Therapy Biomanufacturing Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Cell Gene Therapy Biomanufacturing Sales Forecast by Country (2026-2035) & (K Units)
Table 118. North America Cell Gene Therapy Biomanufacturing Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Cell Gene Therapy Biomanufacturing Sales Forecast by Country (2026-2035) & (K Units)
Table 120. Europe Cell Gene Therapy Biomanufacturing Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Cell Gene Therapy Biomanufacturing Sales Forecast by Region (2026-2035) & (K Units)
Table 122. Asia Pacific Cell Gene Therapy Biomanufacturing Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Cell Gene Therapy Biomanufacturing Sales Forecast by Country (2026-2035) & (K Units)
Table 124. South America Cell Gene Therapy Biomanufacturing Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Cell Gene Therapy Biomanufacturing Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Cell Gene Therapy Biomanufacturing Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Cell Gene Therapy Biomanufacturing Sales Forecast by Type (2026-2035) & (K Units)
Table 128. Global Cell Gene Therapy Biomanufacturing Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Cell Gene Therapy Biomanufacturing Price Forecast by Type (2026-2035) & (USD/Unit)
Table 130. Global Cell Gene Therapy Biomanufacturing Sales (K Units) Forecast by Application (2026-2035)
Table 131. Global Cell Gene Therapy Biomanufacturing Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Cell Gene Therapy Biomanufacturing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell Gene Therapy Biomanufacturing Market Size (M USD), 2025-2035
Figure 5. Global Cell Gene Therapy Biomanufacturing Market Size (M USD) (2020-2035)
Figure 6. Global Cell Gene Therapy Biomanufacturing Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell Gene Therapy Biomanufacturing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cell Gene Therapy Biomanufacturing Product Life Cycle
Figure 13. Cell Gene Therapy Biomanufacturing Sales Share by Manufacturers in 2025
Figure 14. Global Cell Gene Therapy Biomanufacturing Revenue Share by Manufacturers in 2025
Figure 15. Cell Gene Therapy Biomanufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Cell Gene Therapy Biomanufacturing Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cell Gene Therapy Biomanufacturing Revenue in 2025
Figure 18. Industry Chain Map of Cell Gene Therapy Biomanufacturing
Figure 19. Global Cell Gene Therapy Biomanufacturing Market PEST Analysis
Figure 20. Global Cell Gene Therapy Biomanufacturing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cell Gene Therapy Biomanufacturing Market Share by Type
Figure 27. Sales Market Share of Cell Gene Therapy Biomanufacturing by Type (2020-2025)
Figure 28. Sales Market Share of Cell Gene Therapy Biomanufacturing by Type in 2025
Figure 29. Market Share of Cell Gene Therapy Biomanufacturing by Type (2020-2025)
Figure 30. Market Share of Cell Gene Therapy Biomanufacturing by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cell Gene Therapy Biomanufacturing Market Share by Application
Figure 33. Global Cell Gene Therapy Biomanufacturing Sales Market Share by Application (2020-2025)
Figure 34. Global Cell Gene Therapy Biomanufacturing Sales Market Share by Application in 2025
Figure 35. Global Cell Gene Therapy Biomanufacturing Market Share by Application (2020-2025)
Figure 36. Global Cell Gene Therapy Biomanufacturing Market Share by Application in 2025
Figure 37. Global Cell Gene Therapy Biomanufacturing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cell Gene Therapy Biomanufacturing Sales Market Share by Region (2020-2025)
Figure 39. Global Cell Gene Therapy Biomanufacturing Market Size by Region (2020-2025)
Figure 40. North America Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Cell Gene Therapy Biomanufacturing Sales Market Share by Country in 2024
Figure 43. North America Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cell Gene Therapy Biomanufacturing Market Size by Country in 2024
Figure 45. U.S. Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cell Gene Therapy Biomanufacturing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Cell Gene Therapy Biomanufacturing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cell Gene Therapy Biomanufacturing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cell Gene Therapy Biomanufacturing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Cell Gene Therapy Biomanufacturing Sales Market Share by Country in 2024
Figure 53. Europe Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cell Gene Therapy Biomanufacturing Market Size by Country in 2024
Figure 55. Germany Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cell Gene Therapy Biomanufacturing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Cell Gene Therapy Biomanufacturing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cell Gene Therapy Biomanufacturing Market Size by Region in 2024
Figure 68. China Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cell Gene Therapy Biomanufacturing Sales and Growth Rate (K Units)
Figure 79. South America Cell Gene Therapy Biomanufacturing Sales Market Share by Country in 2024
Figure 80. South America Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (M USD)
Figure 81. South America Cell Gene Therapy Biomanufacturing Market Size by Country in 2024
Figure 82. Brazil Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cell Gene Therapy Biomanufacturing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Cell Gene Therapy Biomanufacturing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cell Gene Therapy Biomanufacturing Market Size by Region in 2024
Figure 92. Saudi Arabia Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cell Gene Therapy Biomanufacturing Production Market Share by Region (2020-2025)
Figure 103. North America Cell Gene Therapy Biomanufacturing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Cell Gene Therapy Biomanufacturing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Cell Gene Therapy Biomanufacturing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Cell Gene Therapy Biomanufacturing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Cell Gene Therapy Biomanufacturing Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Cell Gene Therapy Biomanufacturing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Cell Gene Therapy Biomanufacturing Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Cell Gene Therapy Biomanufacturing Market Share Forecast by Type (2026-2035)
Figure 111. Global Cell Gene Therapy Biomanufacturing Sales Forecast by Application (2026-2035)
Figure 112. Global Cell Gene Therapy Biomanufacturing Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Cell Gene Therapy Biomanufacturing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell Gene Therapy Biomanufacturing Market Size (M USD), 2025-2035
Figure 5. Global Cell Gene Therapy Biomanufacturing Market Size (M USD) (2020-2035)
Figure 6. Global Cell Gene Therapy Biomanufacturing Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell Gene Therapy Biomanufacturing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cell Gene Therapy Biomanufacturing Product Life Cycle
Figure 13. Cell Gene Therapy Biomanufacturing Sales Share by Manufacturers in 2025
Figure 14. Global Cell Gene Therapy Biomanufacturing Revenue Share by Manufacturers in 2025
Figure 15. Cell Gene Therapy Biomanufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Cell Gene Therapy Biomanufacturing Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cell Gene Therapy Biomanufacturing Revenue in 2025
Figure 18. Industry Chain Map of Cell Gene Therapy Biomanufacturing
Figure 19. Global Cell Gene Therapy Biomanufacturing Market PEST Analysis
Figure 20. Global Cell Gene Therapy Biomanufacturing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cell Gene Therapy Biomanufacturing Market Share by Type
Figure 27. Sales Market Share of Cell Gene Therapy Biomanufacturing by Type (2020-2025)
Figure 28. Sales Market Share of Cell Gene Therapy Biomanufacturing by Type in 2025
Figure 29. Market Share of Cell Gene Therapy Biomanufacturing by Type (2020-2025)
Figure 30. Market Share of Cell Gene Therapy Biomanufacturing by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cell Gene Therapy Biomanufacturing Market Share by Application
Figure 33. Global Cell Gene Therapy Biomanufacturing Sales Market Share by Application (2020-2025)
Figure 34. Global Cell Gene Therapy Biomanufacturing Sales Market Share by Application in 2025
Figure 35. Global Cell Gene Therapy Biomanufacturing Market Share by Application (2020-2025)
Figure 36. Global Cell Gene Therapy Biomanufacturing Market Share by Application in 2025
Figure 37. Global Cell Gene Therapy Biomanufacturing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cell Gene Therapy Biomanufacturing Sales Market Share by Region (2020-2025)
Figure 39. Global Cell Gene Therapy Biomanufacturing Market Size by Region (2020-2025)
Figure 40. North America Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Cell Gene Therapy Biomanufacturing Sales Market Share by Country in 2024
Figure 43. North America Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cell Gene Therapy Biomanufacturing Market Size by Country in 2024
Figure 45. U.S. Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cell Gene Therapy Biomanufacturing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Cell Gene Therapy Biomanufacturing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cell Gene Therapy Biomanufacturing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cell Gene Therapy Biomanufacturing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Cell Gene Therapy Biomanufacturing Sales Market Share by Country in 2024
Figure 53. Europe Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cell Gene Therapy Biomanufacturing Market Size by Country in 2024
Figure 55. Germany Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cell Gene Therapy Biomanufacturing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Cell Gene Therapy Biomanufacturing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cell Gene Therapy Biomanufacturing Market Size by Region in 2024
Figure 68. China Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cell Gene Therapy Biomanufacturing Sales and Growth Rate (K Units)
Figure 79. South America Cell Gene Therapy Biomanufacturing Sales Market Share by Country in 2024
Figure 80. South America Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (M USD)
Figure 81. South America Cell Gene Therapy Biomanufacturing Market Size by Country in 2024
Figure 82. Brazil Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cell Gene Therapy Biomanufacturing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Cell Gene Therapy Biomanufacturing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cell Gene Therapy Biomanufacturing Market Size by Region in 2024
Figure 92. Saudi Arabia Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cell Gene Therapy Biomanufacturing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Cell Gene Therapy Biomanufacturing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cell Gene Therapy Biomanufacturing Production Market Share by Region (2020-2025)
Figure 103. North America Cell Gene Therapy Biomanufacturing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Cell Gene Therapy Biomanufacturing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Cell Gene Therapy Biomanufacturing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Cell Gene Therapy Biomanufacturing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Cell Gene Therapy Biomanufacturing Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Cell Gene Therapy Biomanufacturing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Cell Gene Therapy Biomanufacturing Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Cell Gene Therapy Biomanufacturing Market Share Forecast by Type (2026-2035)
Figure 111. Global Cell Gene Therapy Biomanufacturing Sales Forecast by Application (2026-2035)
Figure 112. Global Cell Gene Therapy Biomanufacturing Market Share Forecast by Application (2026-2035)
